Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Practice Guidelines

Background:

• Upper gastrointestinal bleeding (UGIB), particularly peptic ulcer bleeding, is a significant cause of mortality and hospitalization globally.
• Regional variations in Helicobacter pylori infection, drug metabolism, and socioeconomic factors necessitate localized guidelines for UGIB management in Asia.
• Existing international consensus requires re-evaluation with data specific to Asian populations.

Framework:

• The working group, comprising experts from 12 Asian countries, developed recommendations for non-variceal UGIB.
• Emphasis was placed on utilizing data generated from the Asian region to tailor clinical practice.
• Key recommendations focus on risk stratification, endoscopic intervention, and pharmacological management.

Implementation:

• The Blatchford score is recommended for selecting patients needing endoscopic intervention, facilitating early discharge for low-risk individuals.
• Patient comorbid conditions must be integrated into the risk assessment process.
• Proton pump inhibitors (PPIs) are crucial: pre-endoscopy PPIs as a stop-gap, endoscopic treatment with PPIs for adherent clots, and high-dose IV/oral PPIs are recommended, while low-dose IV PPIs should be avoided.

Implications:

• Guidelines support the use of COX-2 selective non-steroidal anti-inflammatory drugs with PPIs for very high-risk UGIB patients.
• Aspirin resumption post-stabilization is advised; clopidogrel alone offers no additional safety over aspirin plus PPI.
• Prophylactic PPI use is recommended when dual antiplatelet agents are administered to mitigate gastrointestinal adverse events.